Analytical Data
-
Gene name
RPL36AL
- Application
-
Alternative Names
RPL36AL; 60S ribosomal protein L36a-like; Large ribosomal subunit protein eL42-like
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q969Q0
-
Expression Region
1-106aa
-
Molecular Weight
39.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RPL36AL, a member of the ribosomal protein family, is encoded by the RPL36AL gene located on chromosome 19. This protein plays a crucial role in the assembly and function of the ribosome, which is essential for protein synthesis in all living organisms. Recent studies have highlighted the importance of ribosomal proteins like RPL36AL in various cellular processes beyond their classical role in ribosome biogenesis. Alterations in RPL36AL expression have been associated with several diseases, particularly cancer, suggesting that it may contribute to tumorigenesis through its influence on cell growth, proliferation, and the modulation of the cellular stress response. Moreover, the potential involvement of RPL36AL in the regulation of mRNA translation makes it an intriguing target for further investigation, particularly in the context of the cancer microenvironment and therapeutic resistance. Understanding the precise role of RPL36AL and its regulatory mechanisms could provide insights into novel therapeutic strategies for cancer treatment and enhance our understanding of ribosomal protein contributions to cellular function and disease. This growing body of research underscores the significance of RPL36AL as a biomarker and therapeutic target, paving the way for future studies aimed at elucidating its role in health and disease.
